COMMUNIQUÉS West-GlobeNewswire

Ultragenyx Expands Leadership Team and Appoints Dr. Wladimir Hogenhuis as Chief Operating Officer
17/09/2018
NOVATO, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today [...]
FDA Grants Rare Pediatric Disease Designation to Cellectar Biosciences’ CLR 131 for the Treatment of Osteosarcoma
17/09/2018
MADISON, Wis., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the [...]
Menlo Therapeutics Begins European Prurigo Nodularis Phase 3 Trial and Presents Additional Data from PN Phase 2 Trial at EADV
17/09/2018
~Additional Exploratory Analyses of Phase 2 Clinical Trial of Serlopitant in Prurigo Nodularis Presented at the European Academy of Dermatology and Venereology Congress~ REDWOOD CITY, Calif., Sept. 17, 2018 (GLOBE [...]
Novo Nordisk A/S - Share repurchase programme
17/09/2018
Bagsværd, Denmark, 17 September 2018 - On 10 August 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]
Avivagen Announces Approval from TSX Venture Exchange for Extension of Warrants
17/09/2018
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. OTTAWA, Sept. 17, 2018 (GLOBE NEWSWIRE) -- [...]
Tabula Rasa HealthCare’s Newly Acquired Subsidiary, Mediture, Expands Managed Long-term Care Services with Visiting Nurse Service of New York
17/09/2018
MOORESTOWN, N.J., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC) , a healthcare technology company advancing the field of medication safety, today announced its subsidiary, [...]
Apotheca Biosciences (PCFP) Overviews Pain-Patch, an Opioid Substitution
17/09/2018
Saint Petersburg, FL, Sept. 17, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Apotheca Biosciences (OTC PINK: PCFP), a developer of cutting-edge medical products, nutraceuticals, drug formulations and cannabis delivery [...]
VBL Therapeutics to Present at Upcoming Conferences in October
17/09/2018
TEL AVIV, Israel, Sept. 17, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]
Eidos Therapeutics Presents Data from its Phase 1 Clinical Trial of AG10 at the 22nd Annual Scientific Meeting of the Heart Failure Society of America
17/09/2018
SAN FRANCISCO, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Eidos Therapeutics , Inc. (Eidos) (Nasdaq:EIDX) announced the presentation of results from its Phase 1 clinical trial of AG10 during a poster session at the 22 nd Annual [...]
Spring Bank Pharmaceuticals, Inc. to Present at the 2018 Cantor Global Healthcare Conference
17/09/2018
HOPKINTON, Mass., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]
Retrotope Announces the Initiation of Expanded Access (Compassionate Use) Trial of RT001 in Amyotrophic Lateral Sclerosis (ALS)
17/09/2018
First ALS patient dosed with RT001 LOS ALTOS, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Retrotope today announced that it has supplied its drug RT001 for the initiation of an expanded access (EA) trial to treat [...]
Coherus BioSciences Management to Present at the 2018 Cantor Global Healthcare Conference in October
17/09/2018
REDWOOD CITY, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that senior management will be presenting at the 2018 Cantor Global Healthcare Conference being held in [...]
Conformis Announces Settlement of Patent Dispute with Smith & Nephew
17/09/2018
Conformis to Receive $10.5 Million for Non-Exclusive License to Patient-Specific Instrument Patents for use with off-the-shelf knee implants BILLERICA, Mass., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: [...]
CRISPR Therapeutics and ViaCyte Announce Strategic Collaboration to Develop Gene-Edited Stem Cell-Derived Therapy for Diabetes
17/09/2018
- Aims to develop an immune-evasive stem cell therapy as a potentially curative treatment for diabetes - - Parties will collaborate through commercialization and share costs and profits worldwide - ZUG, Switzerland and [...]
Aeglea BioTherapeutics Announces Oral Presentation of Preclinical Data on New Pipeline Therapeutic for Cystinuria at 2018 American Society of Nephrology
17/09/2018
AUSTIN, Texas, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare [...]
Pivotal Phase 3 Data from CONVERT Study of ALIS in Patients with Treatment-Refractory NTM Lung Disease Caused by MAC Published in American Journal of Respiratory and Critical Care Medicine
17/09/2018
--As previously reported, study met primary endpoint of culture conversion (p<0.0001)-- --ALIS under FDA Priority Review with PDUFA action date of September 28, 2018-- BRIDGEWATER, N.J., Sept. 17, 2018 (GLOBE [...]
Aphios Pharma LLC Announces Reg. CF Private Placement Offering
17/09/2018
WOBURN, Mass., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Aphios ® Pharma LLC is pleased to announce the launch of a private placement offering in accordance with Regulation Crowdfunding (Reg. CF) adopted by the U.S. Securities [...]
Greg Matz Joins Daré Bioscience Board of Directors
17/09/2018
SAN DIEGO, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s biopharmaceutical company, today announced the appointment of Greg Matz to its board of directors. Most [...]
Soleno Therapeutics to Present DCCR Clinical Data at Late Breaking Sessions of the European Society for Paediatric Endocrinology
17/09/2018
REDWOOD CITY, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases will present [...]

Pages